Document is current

Article History

Received: 4 July 2021

Accepted: 16 March 2022

First Online: 14 April 2022

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: During the past 3 years, CL has received research grants, speaker or consultancy fees from AstraZeneca S.p.A., Boehringer Ingelheim Italia S.p.A., CSL Behring S.p.A., Ferring S.p.A., Ipsen S.p.A., Roche S.p.A., Sanofi S.r.l., Santen GmbH, Shire S.p.A, Sobi S.p.A.RB has served on scientific advisory boards for Biogen, Merck-Serono, Novartis, Sanofi-Genzyme; received research support from Almirall, Bayer, Biogen, Merck-Serono, Novartis, Sanofi-Genzyme; received support for travel and congress from Biogen, Roche, Merck-Serono, Sanofi-Genzyme, Teva; received honoraria for speaking engagement from Biogen, Merck-Serono, Novartis, Sanofi-Genzyme.MZ has served on scientific advisory boards and received honoraria for speaking or support for travel and congress attendance from Almirall, Biogen, Merck-Serono, Novartis, Sanofi-Genzyme.During the past 3 years, RT has received speaker or consultancy fees from Biogen, Merck-Serono, Novartis, Roche, Sanofi and Teva.DP has received honoraria for consultancy and/or speaking from Biogen Idec, Merck-Serono, Bayer-Schering, Sanofi-Aventis, TEVA, Novartis and Genzyme.